Hubei Junxian Biotechnology Co., Ltd

Firmenname:Hubei Junxian Biotechnology Co., Ltd

Telefon:

E-Mail:3464928989@qq.com

Nationalität:China

Produkte insgesamt:46

Produktkatalog

Vandetanib	443913-73-3	C22H24BrFN4O2
Olaparib	763113-22-0	C24H23FN4O3
Nintedanib	656247-18-6	C33H39N5O7S
Osimertinib	1421373-65-0	C28H33N7O2
PF-06463922	1454846-35-5	C21H19FN6O2
Afatinib	439081-18-2	C24H25ClFN5O3
Crizotinib	877399-52-5	C21H22Cl2FN5O
Cediranib Maleate	857036-77-2	C25H27FN4O3·C4H4O4
CABOZANTINIB	1140909-48-3	C32H30FN3O10
Dacomitinib	1110813-31-4	C24H25ClFN5O2
Poziotinib	1092364-38-9	C23H21Cl2FN4O3
AMG 510	2252403-56-6	C30H30F2N6O3
Neratinib	698387-09-6	C30H29ClN6O3
Regorafenib	755037-03-7	C21H15ClF4N4O3
Trametinib	871700-17-3	C26H23FIN5O4
Dabrafenib	1195765-45-7	C23H20F3N5O2S2
LOXO-292	2152628-33-4	C29H31N7O3
lenvatinib Mesylate	857890-39-2	C22H23ClN4O7S
Brigatinib	1197953-54-0	C29H39ClN7O2P
Regorafenib hydrate	1019206-88-2	C21H17ClF4N4O4
AZD3759	1626387-80-1	C22H23ClFN5O3
ABT-494	1310726-60-3	C17H19F3N6O
LOXO-101	1223403-58-4	C21H22F2N6O2
Niraparib tosylate	1613220-15-7	C26H28N4O4S
KIT/PDGFR INHIBITOR(DCC-2618)	1442472-39-0	C24H21BrFN5O2
Afatinib	850140-72-6	C24H25ClFN5O3
Alectinib	1256580-46-7	C30H34N4O2
INCB28060	1197376-85-4	C23H18ClFN6O
Bosutinib	380843-75-4	C26H29Cl2N5O3
AMG-510	2296729-00-3	C30H30F2N6O3
Nintedanib	656247-17-5	C31H33N5O4
Cabozantinib	849217-68-1	C28H24FN3O5
Dabrafenib Mesylate	1195768-06-9	C24H24F3N5O5S3
TAK-788	1847461-43-1	C32H39N7O4
axitinib	319460-85-0	C22H18N4OS
Selumetinib	606143-52-6	C17H15BrClFN4O3
Tivozanib	475108-18-0	C22H19ClN4O5
MK-1775	955365-80-7	C27H32N8O2
Binimetinib	606143-89-9	C17H15BrF2N4O3
ceritinib	1032900-25-6	C28H36ClN5O3S
EAI-045	1942114-09-1	C19H14FN3O3S
TPX-0005	1802220-02-5	C18H18FN5O2
Pazopanib	444731-52-6	C21H23N7O2S
INCB28060	1029712-80-8	C23H17FN6O
Entrectinib	1108743-60-7	C31H34F2N6O2
CEP-40783	1437321-24-8	C31H26F2N4O6